JP Morgan Chase
AMED

JP Morgan Chase’s Amedisys AMED Stock Holding History

JP Morgan Chase’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-126,588
Closed -$12.5M – 7371
2025
Q2 		$12.5M Buy
126,588
+23,162
+22% +$2.19M ﹤0.01% 2355
2025
Q1 		$9.58M Buy
103,426
+14,993
+17% +$1.38M ﹤0.01% 2576
2024
Q4 		$8.03M Buy
88,433
+4,104
+5% +$377K ﹤0.01% 2909
2024
Q3 		$8.14M Sell
84,329
-4,307
-5% -$420K ﹤0.01% 2781
2024
Q2 		$8.14M Sell
88,636
-8,346
-9% -$774K ﹤0.01% 2638
2024
Q1 		$8.94M Sell
96,982
-83,769
-46% -$7.85M ﹤0.01% 2587
2023
Q4 		$17.2M Buy
180,751
+97,017
+116% +$9.06M ﹤0.01% 1974
2023
Q3 		$7.82M Sell
83,734
-1,012,585
-92% -$93.6M ﹤0.01% 2479
2023
Q2 		$100M Sell
1,096,319
-900,711
-45% -$73.9M 0.01% 821
2023
Q1 		$147M Buy
1,997,030
+237,160
+13% +$20.5M 0.02% 643
2022
Q4 		$147M Buy
1,759,870
+58,365
+3% +$5.26M 0.02% 619
2022
Q3 		$165M Buy
1,701,505
+15,565
+0.9% +$1.86M 0.02% 549
2022
Q2 		$177M Buy
1,685,940
+301,899
+22% +$38.6M 0.02% 543
2022
Q1 		$238M Buy
1,384,041
+304,375
+28% +$45.5M 0.03% 513
2021
Q4 		$175M Buy
1,079,666
+258,007
+31% +$41.5M 0.02% 625
2021
Q3 		$123M Sell
821,659
-443,421
-35% -$92.2M 0.02% 776
2021
Q2 		$310M Buy
1,265,080
+97,351
+8% +$25.5M 0.04% 474
2021
Q1 		$309M Buy
1,167,729
+30,187
+3% +$8.51M 0.04% 445
2020
Q4 		$334M Buy
1,137,542
+82,251
+8% +$21.1M 0.05% 376
2020
Q3 		$245M Buy
1,055,291
+74,250
+8% +$16.9M 0.04% 414
2020
Q2 		$195M Buy
981,041
+101,225
+12% +$18.9M 0.04% 448
2020
Q1 		$161M Buy
879,816
+2,458
+0.3% +$437K 0.04% 436
2019
Q4 		$146M Sell
877,358
-135,516
-13% -$20.2M 0.03% 531
2019
Q3 		$133M Buy
1,012,874
+59,672
+6% +$7.77M 0.03% 572
2019
Q2 		$114M Buy
953,202
+45,383
+5% +$5.39M 0.02% 630
2019
Q1 		$112M Sell
907,819
-2,378
-0.3% -$298K 0.02% 611
2018
Q4 		$107M Sell
910,197
-23,940
-3% -$2.82M 0.02% 603
2018
Q3 		$117M Buy
934,137
+118,936
+15% +$13.1M 0.02% 630
2018
Q2 		$69.7M Buy
815,201
+202,231
+33% +$14.8M 0.01% 811
2018
Q1 		$37M Buy
612,970
+572,566
+1,417% +$32.6M 0.01% 1110
2017
Q4 		$2.13M Buy
40,404
+30,008
+289% +$1.58M ﹤0.01% 3281
2017
Q3 		$577K Sell
10,396
-28,045
-73% -$1.48M ﹤0.01% 3779
2017
Q2 		$2.42M Sell
38,441
-34,310
-47% -$2M ﹤0.01% 2930
2017
Q1 		$3.72M Sell
72,751
-19,573
-21% -$934K ﹤0.01% 2629
2016
Q4 		$3.94M Buy
92,324
+47,715
+107% +$2.03M ﹤0.01% 2640
2016
Q3 		$2.12M Buy
44,609
+18,110
+68% +$904K ﹤0.01% 2774
2016
Q2 		$1.34M Buy
26,499
+21,241
+404% +$1.07M ﹤0.01% 3022
2016
Q1 		$254K Hold
5,258
– – ﹤0.01% 3542
2015
Q4 		$207K Buy
+5,258
New +$210K ﹤0.01% 3642
2015
Q2 		– Sell
-37,453
Closed -$1M – 4004
2015
Q1 		$1M Buy
37,453
+6,481
+21% +$183K ﹤0.01% 3233
2014
Q4 		$909K Sell
30,972
-437,458
-93% -$10.8M ﹤0.01% 3392
2014
Q3 		$9.45M Sell
468,430
-398,597
-46% -$7.69M ﹤0.01% 1958
2014
Q2 		$14.5M Buy
867,027
+345,111
+66% +$4.89M ﹤0.01% 1523
2014
Q1 		$7.77M Buy
521,916
+17,611
+3% +$271K ﹤0.01% 1853
2013
Q4 		$7.38M Sell
504,305
-19,593
-4% -$315K ﹤0.01% 1933
2013
Q3 		$9.02M Buy
523,898
+31,937
+6% +$474K ﹤0.01% 1817
2013
Q2 		$5.71M Buy
+491,961
New +$5.64M ﹤0.01% 2045

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's AMED Position: Q3 2025 in Review

JP Morgan Chase sold out of Amedisys (AMED) in Q3 2025, closing a stake of 126,588 shares — an estimated $12.5M sold.

JP Morgan Chase first reported a position in AMED in Q2 2013 and held it in 47 quarters. The position peaked at $334M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • JP Morgan Chase reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 126,588 Amedisys shares in Q3 2025, an estimated $12.5M.
  • JP Morgan Chase first reported a position in Amedisys in Q2 2013 and held it in 47 quarters.
  • JP Morgan Chase's Amedisys position peaked at $334M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.